[optimal] Re: (no subject)

  • From: Peterson John C <JPeterson@xxxxxxxxxxxx>
  • To: "'optimal@xxxxxxxxxxxxx'" <optimal@xxxxxxxxxxxxx>
  • Date: Fri, 24 Apr 2015 16:52:13 +0000

What she said.

- John

-----Original Message-----
From: optimal-bounce@xxxxxxxxxxxxx [mailto:optimal-bounce@xxxxxxxxxxxxx] On
Behalf Of Cunningham, Denise (NIH/NEI) [E]
Sent: Friday, April 24, 2015 11:51 AM
To: <optimal@xxxxxxxxxxxxx>
Subject: [optimal] Re: (no subject)

Never.

On Apr 24, 2015, at 12:34 PM, "Paula Morris"
<paula.morris@xxxxxxxxxxxx<mailto:paula.morris@xxxxxxxxxxxx>> wrote:

Hello colleagues,

I have received an inquiry from the UK about how often Spectralis users in the
US enter the c-curve information when imaging clinical patients, not just in
clinical trials.

Thanks so much for sharing,

P


Other related posts: